Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

as adenosine a 2b Receptor antagonists and melatonin mt 3 2-aminopyridine derivatives of receptor ligands

A technology of pyridine and fluoropyridine, applied in the field of pyridine derivatives, can solve the problems of limiting the pro-inflammatory effect of adenosine

Active Publication Date: 2020-06-26
PALOBIOFARMA SL
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Antagonists of this receptor would likely limit the pro-inflammatory effects of adenosine

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • as adenosine a <sub>2b</sub> Receptor antagonists and melatonin mt <sub>3</sub> 2-aminopyridine derivatives of receptor ligands
  • as adenosine a <sub>2b</sub> Receptor antagonists and melatonin mt <sub>3</sub> 2-aminopyridine derivatives of receptor ligands
  • as adenosine a <sub>2b</sub> Receptor antagonists and melatonin mt <sub>3</sub> 2-aminopyridine derivatives of receptor ligands

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0262] Example 1 : 5-(pyridin-4-yl)-6-(pyrimidin-5-yl)pyridin-2-amine

[0263]

[0264] 5-Iodo-6-(pyrimidin-5-yl)pyridin-2-amine (0.53 g, 1.77 mmol) and (pyridin-4-yl)boronic acid pinacol ester (0.91 g, 4.42 mmoles), [1, 1'bis(diphenylphosphino)ferrocene]dichloropalladium(II) - complexed with dichloromethane (0.087g, 0.107mmoles), and 1,4-bis A mixture of 2M aqueous cesium carbonate solution (3.6 mL) in alkanes (14.3 mL) was heated to 110 °C and left to stir for 20 hours. The mixture was cooled and then partitioned between ethyl acetate and 1M aqueous sodium hydroxide solution. Partition the organic phase with sodium bicarbonate and brine. dry (MgSO 4) and evaporate the final organic layer. The residue precipitated as a pale pink fine solid which was rinsed with cold diethyl ether and dried (0.286 g, 54.8%).

[0265] 1 H-NMR (400MHz, DMSO-d 6 ): δ=6.52(s, 2H), 6.64(d, 1H), 7.13(d, 2H), 7.58(d, 1H), 8.44(d, 2H), 8.61(s, 2H), 9.09(s, 1H).

[0266] HPLC-MS: Rt 1.88...

Embodiment 2

[0267] Example 2 : 5-(3-fluoropyridin-4-yl)-6-(pyrimidin-5-yl)pyridin-2-amine

[0268] Following the procedure described in Example 1, this product was synthesized from 6-(pyrimidin-5-yl)pyridin-2-amine and 3-fluoropyridine-4-boronic acid.

[0269] 1 H-NMR (400MHz, DMSO-d 6 ): δ=6.61(s, 2H), 6.65(d, 1H), 7.38(dd, 1H), 7.57(d, 1H), 8.39(d, 1H), 8.43(d, 1H), 8.62(s, 2H), 9.10(s, 1H).

[0270] HPLC-MS: Rt 2.082m / z 268.0 (MH + ).

Embodiment 3

[0271] Example 3 : 6-(pyridin-3-yl)-5-(pyridin-4-yl)pyridin-2-amine

[0272] Following the procedure described in Example 1, this product was synthesized from 6-(pyridin-3-yl)pyridin-2-amine and pyridine-4-boronic acid.

[0273] 1 H-NMR (400MHz, DMSO-d 6 ): δ=6.42(s, 2H), 6.59(d, 1H), 7.06(d, 2H), 7.30(dd, 1H), 7.55(d, 1H), 7.63(d, 1H), 8.37(d, 1H), 8.39(d, 2H), 8.46(d, 1H).

[0274] HPLC-MS: Rt 2.804m / z 249.1 (MH + ).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to as A 2B Adenosine receptor antagonists and MT 3 Novel pyridine derivatives of formula (I) as ligands for the melatonin receptor, processes for their preparation, pharmaceutical compositions comprising said compounds and manufacture for the treatment of 2B receptor and by inhibiting MT 3 Use in medicine for pathological conditions or diseases ameliorated by melatonin receptors such as respiratory diseases, metabolic disorders, neurological disorders and cancers:

Description

technical field [0001] The present invention relates to as A 2B Adenosine receptor antagonists and MT 3 Novel pyridine derivatives of ligands for the melatonin receptor. [0002] Other objects of the present invention are to provide a method for preparing said compound; a pharmaceutical composition comprising an effective amount of said compound; 2B receptor and by inhibiting MT 3 Use in medicine for pathological conditions or diseases which are ameliorated by melatonin receptors, such as respiratory diseases, metabolic disorders, neurological disorders and cancers. Background technique [0003] Adenosine passes through four subtypes of receptors—A 1 、A 2A 、A 2B and A 3 - adjust its function. These receptors are grouped according to their action on adenylate cyclase. A 1 and A 3 Receptors inhibit cAMP production by coupling to G proteins. A 2A and A 2B The receptor increases cAMP levels by stimulating an enzyme - adenylate cyclase - and also by coupling to G pr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D401/14A61K31/444A61K31/506A61P11/06A61P11/00A61P3/04A61P3/10A61P9/10A61P25/16A61P25/28A61P35/00
CPCC07D401/14A61K31/444A61K31/506A61K45/06A61P11/00A61P11/06A61P11/08A61P25/16A61P25/28A61P3/04A61P35/00A61P3/06A61P3/08A61P43/00A61P9/10A61P3/10C07D213/73A61K31/4412A61K2300/00
Inventor J·C·卡斯特罗-巴洛米诺马拉里亚J·A·卡马乔古梅兹A·门多萨里咂尔德斯
Owner PALOBIOFARMA SL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com